Skip to main content

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY: PLX )

1.359 +0.109 (+8.70%)
Streaming Delayed Price Updated: 12:37 PM EST, Nov 4, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
July 17, 2012
Form 4
Source: SEC/Edgar
July 17, 2012
Form 4
Source: SEC/Edgar
July 17, 2012
Form 4
Source: SEC/Edgar
July 17, 2012
Form 4
Source: SEC/Edgar
July 17, 2012
Form 4
Source: SEC/Edgar
July 17, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
October 07, 2010
Form 4
Source: SEC/Edgar
October 05, 2010
Form 4
Source: SEC/Edgar
September 07, 2010
Form 4
Source: SEC/Edgar
September 07, 2010
Form 3
Source: SEC/Edgar
September 06, 2010
Form 4
Source: SEC/Edgar
September 06, 2010
Form 4
Source: SEC/Edgar
August 08, 2010
Form 4
Source: SEC/Edgar
June 22, 2010
Form 4
Source: SEC/Edgar
May 02, 2010
Form 4
Source: SEC/Edgar
April 15, 2010
Form 4
Source: SEC/Edgar
March 24, 2010
Form 4
Source: SEC/Edgar
February 25, 2010
Form 4
Source: SEC/Edgar
February 25, 2010
Form 4
Source: SEC/Edgar
February 25, 2010
Form 4
Source: SEC/Edgar
February 25, 2010
Form 4
Source: SEC/Edgar
February 08, 2010
Form 3
Source: SEC/Edgar
December 22, 2009
Form 4
Source: SEC/Edgar
December 08, 2009
Form 4
Source: SEC/Edgar
November 12, 2009
Form 4
Source: SEC/Edgar
October 20, 2009
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.